ATE268782T1 - Zusammensetzungen zur wundheilung - Google Patents

Zusammensetzungen zur wundheilung

Info

Publication number: ATE268782T1
Authority: AT; Austria
Prior art keywords: wound healing; compositions; angiotensin; analogs; mammals
Prior art date: 1997-12-12

Application number

AT98963073T

Other languages

English (en)

Inventor

Kathleen Rodgers

Gere S Dizerega

Original Assignee

Univ Southern California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-12

Filing date

1998-12-11

Publication date

2004-06-15

1998-12-11 Application filed by Univ Southern California filed Critical Univ Southern California

2004-06-15 Application granted granted Critical

2004-06-15 Publication of ATE268782T1 publication Critical patent/ATE268782T1/de

Links

239000000203 mixture Substances 0.000 title abstract 2
230000029663 wound healing Effects 0.000 title abstract 2
CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 abstract 2
102000005862 Angiotensin II Human genes 0.000 abstract 1
101800000733 Angiotensin-2 Proteins 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
229950006323 angiotensin ii Drugs 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/085—Angiotensins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Materials Engineering (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Oral & Maxillofacial Surgery (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Immunology (AREA)
Transplantation (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AT98963073T 1997-12-12 1998-12-11 Zusammensetzungen zur wundheilung ATE268782T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US6966297P	1997-12-12	1997-12-12
PCT/US1998/026347 WO1999031125A1 (en)	1997-12-12	1998-12-11	Wound healing compositions

Publications (1)

Publication Number	Publication Date
ATE268782T1 true ATE268782T1 (de)	2004-06-15

Family

ID=22090435

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98963073T ATE268782T1 (de)	1997-12-12	1998-12-11	Zusammensetzungen zur wundheilung

Country Status (9)

Country	Link
US (3)	US6165978A (de)
EP (1)	EP1036089B1 (de)
JP (1)	JP4347522B2 (de)
AT (1)	ATE268782T1 (de)
AU (1)	AU755225B2 (de)
CA (1)	CA2315266C (de)
DE (1)	DE69824445T2 (de)
TW (1)	TW542843B (de)
WO (1)	WO1999031125A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6528483B2 (en)	1995-06-07	2003-03-04	André Beaulieu	Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en)	1995-06-07	2006-09-26	Andre Beaulieu	Solid wound healing formulations containing fibronectin
US6335195B1 (en) *	1997-01-28	2002-01-01	Maret Corporation	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
DE69824445T2 (de) *	1997-12-12	2005-06-30	University Of Southern California, Los Angeles	Zusammensetzungen zur wundheilung
EP1053004A2 (de)	1998-02-09	2000-11-22	University Of Southern California	Verwendung von angiotensin-analoga zur forderung der erythropoiesis
US6475988B1 (en) *	1998-05-11	2002-11-05	University Of Southern California	Methods to increase white blood cell survival after chemotherapy
US6258778B1 (en)	1998-07-13	2001-07-10	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
US6916783B2 (en)	1998-07-13	2005-07-12	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
AU755943B2 (en)	1998-08-13	2003-01-02	University Of Southern California	Methods to increase blood flow to ischemic tissue
US6730775B1 (en)	1999-03-23	2004-05-04	University Of Southern California	Methods for limiting scar and adhesion formation
US6821953B1 (en)	1999-12-16	2004-11-23	University Of Southern California	Methods for treating and preventing damage to mucosal tissue
AU2001233064A1 (en) *	2000-01-27	2001-08-07	University Of Southern California	Methods for inhibiting smooth muscle cell proliferation
US6747008B1 (en)	2000-06-19	2004-06-08	University Of Southern California	Methods for treating and preventing alopecia
AU2002308522A1 (en) *	2001-05-01	2002-11-11	University Of Southern California	Methods for inhibiting tumor cell proliferation
US7094252B2 (en) *	2001-08-21	2006-08-22	Cooltouch Incorporated	Enhanced noninvasive collagen remodeling
EP1507543A4 (de)	2002-05-09	2006-07-26	Cambridgemed Inc	Pharmazeutische zusammensetzung zur behandlung von wunden mit blutplasma oder serum
DE10361306A1 (de) *	2003-12-24	2005-07-28	Lts Lohmann Therapie-Systeme Ag	Wundauflage und Wundschnellverband mit einem vasokonstriktorischen Inhaltsstoff, sowie Herstellungsverfahren hierfür
BRPI0602372B8 (pt) *	2006-05-18	2021-06-22	Einco Biomaterial Ltda	processo de preparação de compósitos em base de biocerâmicas e polímeros biodegradáveis e produto derivado
WO2009114461A2 (en) *	2008-03-10	2009-09-17	University Of Southern California	Angiotensin (1-7) dosage forms and uses thereof
HRP20151440T1 (hr)	2008-12-29	2016-01-29	Trevena, Inc.	Efektori beta-arestina i sastavi i metode u kojima se koriste
WO2011120032A1 (en) *	2010-03-26	2011-09-29	University Of Southern California	Methods for treating combined radiation and thermal injury
US10279007B2 (en)	2010-11-15	2019-05-07	Oxygenetix Institute, Inc.	Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs
CN102858360B (zh)	2011-02-02	2017-07-25	南加利福尼亚大学	治疗糖尿病足溃疡的方法
CN104302305A (zh) *	2011-12-16	2015-01-21	塔瑞克斯制药有限公司	用于治疗纤维化的血管紧张素
AU2013215269A1 (en)	2012-01-31	2014-08-21	Trevena, Inc.	Beta-arrestin effectors and compositions and methods of use thereof
US9688724B2 (en)	2012-05-14	2017-06-27	University Of Southern California	Methods for limiting development of a skin wound
EP3935944A1 (de)	2013-03-15	2022-01-12	University Of Southern California, USC Stevens	Verbindungen zur behandlung von erkrankungen des bewegungsapparats
WO2014151338A1 (en)	2013-03-15	2014-09-25	University Of Southern California	Methods for treating multiple sclerosis
US9844578B2 (en)	2013-04-30	2017-12-19	University Of Southern California	Accelerated healing of eye injuries by angiotensin peptides
JP6254692B2 (ja)	2013-07-03	2017-12-27	ジアリゾナボードオブリージェンツオンビハーフオブザユニヴァーシティーオブアリゾナ	認知機能不全を治療するための方法
US9518086B2 (en)	2014-02-07	2016-12-13	Trevena, Inc.	Crystalline and amorphous forms of a β-arrestin effector
US9611293B2 (en)	2014-05-19	2017-04-04	Trevena, Inc.	Synthesis of beta-arrestin effectors
US10183055B2 (en)	2014-07-21	2019-01-22	Arizona Board Of Regents On Behalf Of The University Of Arizona	Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
JP6666899B2 (ja)	2014-07-21	2020-03-18	アリゾナボードオブリージェンツオンビハーフオブザユニヴァーシティーオブアリゾナ	Ａｎｇ−（１−７）誘導体オリゴペプチド、ならびにそれを使用および作製するための方法
WO2018002673A1 (en)	2016-07-01	2018-01-04	N4 Pharma Uk Limited	Novel formulations of angiotensin ii receptor antagonists
EP3548035A4 (de)	2016-11-30	2020-07-22	Case Western Reserve University	Kombinationen von 15-pgdh-inhibitoren mit corticosteroiden und/oder tnf-inhibitoren und verwendungen davon
JP2020514323A (ja)	2017-02-06	2020-05-21	ケースウエスタンリザーブユニバーシティ	短鎖デヒドロゲナーゼ活性を調節する組成物と方法
KR102921276B1 (ko)	2018-11-21	2026-02-03	케이스 웨스턴 리저브 유니버시티	단쇄 데히드로게나아제 활성을 조절하는 조성물 및 방법
KR102668789B1 (ko)	2018-11-23	2024-05-24	(주)메디코스바이오텍	창상치료용 약학조성물
AU2021275122A1 (en)	2020-05-20	2022-12-15	Board Of Regents Of The University Of Texas System	Compositions and methods of modulating short-chain dehydrogenase activity
TW202527908A (zh)	2023-11-15	2025-07-16	德商斯特拉醫療有限責任公司	Ｍａｓ及ｍｒｇｄ受體之小分子調節劑

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5015629A (en) *	1989-06-26	1991-05-14	University Of Southern California	Tissue repair
US5955430A (en) *	1993-09-24	1999-09-21	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
WO1995008565A1 (en) *	1993-09-24	1995-03-30	The University Of Southern California	Use of angiotensin ii analogs in tissue repair
AU706333B2 (en) *	1993-09-24	1999-06-17	University Of Southern California	Use of angiotensin III and analogs thereof in tissue repair
US5834432A (en) *	1995-06-06	1998-11-10	The University Of Southern California	Use of angiotensin II Type 2 receptor agonists in tissue repair
US6110895A (en) *	1996-12-16	2000-08-29	University Of Southern California	Method of promoting healing in skin grafts
US6335195B1 (en) *	1997-01-28	2002-01-01	Maret Corporation	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
WO1998033813A2 (en) *	1997-02-04	1998-08-06	University Of Southern California	Method for accelerating healing of thermal injuries
DE69824445T2 (de) *	1997-12-12	2005-06-30	University Of Southern California, Los Angeles	Zusammensetzungen zur wundheilung
AU755943B2 (en) *	1998-08-13	2003-01-02	University Of Southern California	Methods to increase blood flow to ischemic tissue

1998
- 1998-12-11 DE DE69824445T patent/DE69824445T2/de not_active Expired - Lifetime
- 1998-12-11 AT AT98963073T patent/ATE268782T1/de not_active IP Right Cessation
- 1998-12-11 EP EP98963073A patent/EP1036089B1/de not_active Expired - Lifetime
- 1998-12-11 AU AU18177/99A patent/AU755225B2/en not_active Ceased
- 1998-12-11 JP JP2000539048A patent/JP4347522B2/ja not_active Expired - Fee Related
- 1998-12-11 WO PCT/US1998/026347 patent/WO1999031125A1/en not_active Ceased
- 1998-12-11 CA CA002315266A patent/CA2315266C/en not_active Expired - Fee Related
- 1998-12-11 US US09/210,249 patent/US6165978A/en not_active Expired - Lifetime
- 1998-12-14 TW TW087120706A patent/TW542843B/zh not_active IP Right Cessation
2000
- 2000-10-27 US US09/698,354 patent/US6455501B1/en not_active Expired - Lifetime
2002
- 2002-08-06 US US10/213,701 patent/US7022675B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP4347522B2 (ja)	2009-10-21
AU755225B2 (en)	2002-12-05
EP1036089A1 (de)	2000-09-20
CA2315266A1 (en)	1999-06-24
DE69824445T2 (de)	2005-06-30
CA2315266C (en)	2004-08-10
US20030017970A1 (en)	2003-01-23
US6455501B1 (en)	2002-09-24
AU1817799A (en)	1999-07-05
JP2002508391A (ja)	2002-03-19
WO1999031125A1 (en)	1999-06-24
DE69824445D1 (de)	2004-07-15
EP1036089B1 (de)	2004-06-09
US6165978A (en)	2000-12-26
WO1999031125B1 (en)	1999-08-19
TW542843B (en)	2003-07-21
US7022675B2 (en)	2006-04-04

Legal Events

Date	Code	Title	Description
2004-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69824445D1 (de)	2004-07-15	Zusammensetzungen zur wundheilung
DE60042578D1 (de)	2009-09-03	Vorrichtung zur elektrochemischen Erzeugung von Sauerstoff
TR199801679T2 (xx)	2001-06-21	Osteoporoz i�in birle�tirme terapisi.
MX9703609A (es)	1997-08-30	Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido.
FI971610A7 (fi)	1997-04-16	Menetelmä syklisten depsipeptidien sulfonyloimiseksi, sulfenyloimiseks i, ja fosforyloimiseksi
ZA947338B (en)	1995-05-10	Use of angiotensin II and analogs thereof in tissue repair
DE69633340D1 (de)	2004-10-14	Kühlschrank zur sicheren annahme von lieferungen
DE69923979D1 (de)	2005-04-07	Vorrichtung zur erzeugung von ionenstrahlen
ZA981936B (en)	1999-09-06	Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
DK0785948T3 (da)	2003-08-04	Analoger af keratinocyt vækstfaktor
DE59903410D1 (de)	2002-12-19	Hybridprotein zur hemmung der mastzelldegranulation und dessen verwendung
ATE234091T1 (de)	2003-03-15	Thrombin inhibitoren
ATE255632T1 (de)	2003-12-15	Immortalisierung bzw. desimmortalisierung von zellen
TR200000374T2 (tr)	2000-09-21	Akut akciğer harabiyeti ve fibrozitinin alfavbeta6 antagonistleriyle tedavisi.
TR199900310T2 (xx)	1999-04-21	Trombin inhibit�rleri
DE69528256D1 (de)	2002-10-24	Vorrichtung zur isolierung von zellularinhaltsstoffen
DE69840603D1 (de)	2009-04-09	Alpha-ketoamidhaltige multikatalytische protease inhibitoren
DE59915175D1 (de)	2010-07-29	Vorrichtung zur Erzeugung von Plasma
ATE186121T1 (de)	1999-11-15	Verfahren zur bestimmung des präthrombotischen status
BR0114595A (pt)	2003-09-16	Uso de um composto que rompe esteróide sexual que sinaliza para o timo no tratamento de um distúrbio de células t
DE60021590D1 (de)	2005-09-01	Verwendung von baclofen zur behandlung von alkoholismus
EA200000519A1 (ru)	2000-10-30	2-АРИЛБЕНЗО[b]ТИОФЕНЫ, ПОЛЕЗНЫЕ ДЛЯ ЛЕЧЕНИЯ СИНДРОМА ЭСТРОГЕННОЙ НЕДОСТАТОЧНОСТИ
PT783521E (pt)	2003-02-28	Compostos polipeptidos que contem d-2-alquiltriptofano capazes de promover a libertacao da hormona do crescimento
ES2186807T3 (es)	2003-05-16	Inhibidores de trombina.
PT1017958E (pt)	2002-10-31	Enriquecimento em oxigenio de combustao de sistemas de forno de cimento